These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 31245051)

  • 21. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
    Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
    Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.
    Fanouriakis A; Kougkas N; Vassilopoulos D; Fragouli E; Repa A; Sidiropoulos P
    Semin Arthritis Rheum; 2015 Aug; 45(1):60-6. PubMed ID: 25908179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
    Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis.
    Yoo J; Kim HJ; Jung SM; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Oct; 20(10):1593-1605. PubMed ID: 28766857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
    Hellmich B; Holle J; Moosig F
    Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
    Canzian A; Venhoff N; Urban ML; Sartorelli S; Ruppert AM; Groh M; Girszyn N; Taillé C; Maurier F; Cottin V; de Moreuil C; Germain V; Samson M; Jachiet M; Denis L; Rieu V; Smets P; Pugnet G; Deroux A; Durel CA; Aouba A; Cathébras P; Deligny C; Faguer S; Gil H; Godeau B; Lifermann F; Phin-Huynh S; Ruivard M; Bonniaud P; Puéchal X; Kahn JE; Thiel J; Dagna L; Guillevin L; Vaglio A; Emmi G; Terrier B;
    Arthritis Rheumatol; 2021 Mar; 73(3):498-503. PubMed ID: 33001543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
    Nanzer AM; Maynard-Paquette AC; Alam V; Green L; Thomson L; Lam J; Fernandes M; Roxas C; d'Ancona G; Hearn A; Gates J; Agarwal S; Kent BD; Fernando M; D'Cruz DP; Hopkins C; Ismail TF; Dhariwal J; Jackson DJ
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):724-732. PubMed ID: 38211889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.
    Joshi L; Tanna A; McAdoo SP; Medjeral-Thomas N; Taylor SR; Sandhu G; Tarzi RM; Pusey CD; Lightman S
    Ophthalmology; 2015 Jun; 122(6):1262-8. PubMed ID: 25745876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis.
    Philobos M; Perkins A; Karabayas M; Dospinescu P; Fluck N; Kidder D; Chapman FA; Dhaun N; Basu N
    Rheumatol Int; 2021 Oct; 41(10):1811-1814. PubMed ID: 34350491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
    Puéchal X; Iudici M; Perrodeau E; Bonnotte B; Lifermann F; Le Gallou T; Karras A; Blanchard-Delaunay C; Quéméneur T; Aouba A; Aumaître O; Cottin V; Hamidou M; Ruivard M; Cohen P; Mouthon L; Guillevin L; Ravaud P; Porcher R; Terrier B;
    JAMA Netw Open; 2022 Nov; 5(11):e2243799. PubMed ID: 36441554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
    Charles P; Terrier B; Perrodeau É; Cohen P; Faguer S; Huart A; Hamidou M; Agard C; Bonnotte B; Samson M; Karras A; Jourde-Chiche N; Lifermann F; Gobert P; Hanrotel-Saliou C; Godmer P; Martin-Silva N; Pugnet G; Matignon M; Aumaitre O; Viallard JF; Maurier F; Meaux-Ruault N; Rivière S; Sibilia J; Puéchal X; Ravaud P; Mouthon L; Guillevin L;
    Ann Rheum Dis; 2018 Aug; 77(8):1143-1149. PubMed ID: 29695500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulomatosis with polyangiitis: clinical course and outcome of 60 patients from a single center in South India.
    Shobha V; Fathima S; Prakash R
    Clin Exp Med; 2018 Aug; 18(3):347-353. PubMed ID: 29492716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and prognostic characteristics in patients with eosinophilic granulomatosis with polyangitis].
    Chen J; Li J; Yang YJ; Tian XP; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):360-365. PubMed ID: 32370464
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Characteristics of Peripheral Neuropathy in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Single-Center Study in China.
    Zhang Z; Liu S; Guo L; Wang L; Wu Q; Zheng W; Hou Y; Tian X; Zeng X; Zhang F
    J Immunol Res; 2020; 2020():3530768. PubMed ID: 32714994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.